title: Plasma high-density lipoprotein cholesterol but not apolipoprotein A-I is a good correlate of the visceral obesity-insulin resistance dyslipidemic syndrome.
abstract: Apolipoprotein (apo) A-I is a major component of high-density lipoproteins (HDLs), and it has been suggested that measurement of apo A-I may provide additional information in the assessment of coronary heart disease (CHD) risk. In the present study in a sample of 111 men (age [mean +/- SD], 35.3 +/- 6.6 years), we determined whether a low apo A-I concentration is associated with the cluster of metabolic abnormalities that characterize the visceral obesity-insulin resistance dyslipidemic syndrome. For this purpose, the first and fourth quartiles of apo A-I and HDL cholesterol (HDL-C) concentrations were compared in relation to body fat distribution, glucose tolerance, and plasma insulin and lipoprotein levels. Men in the first quartile (< the 25th percentile) of HDL-C, as compared with men in the fourth quartile (> the 75th percentile), were characterized by an elevated visceral adipose tissue (AT) accumulation (P < .05), as well as by increased plasma levels of triglycerides ([TGs] P < .0001), apo B (P < .0005), and insulin (P < .01). These differences were not found when the first and fourth quartiles of plasma apo A-I concentrations were compared. These results suggest that plasma levels of HDL-C are more closely associated with the various features of the visceral obesity-insulin resistance syndrome than plasma apo A-I.
authors.affiliation: Lipid Research Center, CHUL Research Center, Sainte-Foy, Québec, Canada.
authors.forename: C
authors.initials: C
authors.lastname: Couillard
authors.forename: B
authors.initials: B
authors.lastname: Lamarche
authors.forename: A
authors.initials: A
authors.lastname: Tchernof
authors.forename: D
authors.initials: D
authors.lastname: Prud'homme
authors.forename: A
authors.initials: A
authors.lastname: Tremblay
authors.forename: C
authors.initials: C
authors.lastname: Bouchard
authors.forename: S
authors.initials: S
authors.lastname: Moorjani
authors.forename: A
authors.initials: A
authors.lastname: Nadeau
authors.forename: P J
authors.initials: PJ
authors.lastname: Lupien
authors.forename: J P
authors.initials: JP
authors.lastname: Després
mesh_terms: D000273:Adipose Tissue / Q000473:pathology; D000328:Adult; D016632:Apolipoprotein A-I / Q000097:blood*; D008076:Cholesterol, HDL / Q000097:blood*; D003327:Coronary Disease / Q000209:etiology; D005951:Glucose Tolerance Test; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood* / Q000150:complications; D007333:Insulin Resistance / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000097:blood* / Q000150:complications / Q000473:pathology; D012307:Risk Factors; D013577:Syndrome
chemical_list: D016632:Apolipoprotein A-I; D008076:Cholesterol, HDL